Delivery Order SPE2DR25D2003-SPE2DR26FR08J
- Not listed
- On January 7, 2026, the Defense Logistics Agency awarded a $40,985.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,289.44 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for REPATHA 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded delivery order with a completion date of September 26, 2025. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal...
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,652.23 to Amerisourcebergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract carries a firm fixed-price structure with an ultimate completion date of January 12, 2026, and was awarded on a competitive, non-set-aside basis. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,154.79 on October 21, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by October 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,686.85 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on December 29, 2025. This firm fixed price delivery order, which falls under a non-set-aside competitive procurement, is scheduled for ultimate completion by December 30, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to reduce cholesterol levels...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,218.48 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which is neither set-aside nor restricted to specific business categories, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. The award represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,662.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This non-competitive delivery order was issued on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency awarded a $22,095.24 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with a contract ceiling value of $31,271.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR08JDelivery Order
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $16,117.24 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 MG/ML SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. The contract carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime contract vehicle enables comprehensive pharmaceutical support to military healthcare systems worldwide, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. REPATHA, a cardiovascular medication, supports the Defense Health Agency's pharmaceutical procurement needs for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 1/8/26 |